The dose-response and mechanism are identical because the molecule is the same
If a corrected resubmission still gets denied, you have standard Medicare appeal rights, starting with a redetermination request to your plan
Tirzepatide targets postprandial glucose elevations, the blood sugar spikes that happen after eating, through its incretin-based approach
This is especially suspect if nothing else in your routine has changed
Many providers recommend injecting in the evening so that the initial peak, which occurs 24-48 hours later, falls on a day when you can manage symptoms more easily
[22] [23] For patients taking tirzepatide specifically to improve glycemic control, niacin's hyperglycemic effect could theoretically counteract some of tirzepatide's glucose-lowering benefits